Company Number: 14488410

Analysis Date: 2025-07-19 12:44 UTC

Financial Health Assessment for THE LOREM THERAPY LTD

---

1. Financial Health Score: B-

Explanation:
THE LOREM THERAPY LTD shows positive net current assets and net assets over the past two years, indicating a basic level of financial stability typical for a very small, micro-entity company. However, the absolute values are quite low (£81 net assets in 2024), reflecting a "fragile but stable" financial condition. The small scale and limited asset base reduce financial resilience, warranting cautious optimism. Hence, a B- grade, reflecting "stable but vulnerable" financial health.

---

2. Key Vital Signs

Metric	2024 (£)	2023 (£)	Interpretation
Current Assets	543	487	Cash or equivalents and receivables are small but slightly improving, indicating modest liquidity.
Current Liabilities	462	482	Short-term debts are stable, slightly reduced, manageable at this size.
Net Current Assets	81	5	Positive working capital, improving from negligible to a small buffer — a healthy "cash flow pulse."
Net Assets (Shareholders’ Funds)	81	5	Equity increased over the year, showing retained earnings or new capital injection.
Average Number of Employees	0 (both years)	0 (both years)	No employees beyond directors; very lean operation.

Interpretation:

• Positive net current assets indicate the company can cover short-term obligations, a vital sign of liquidity health.
• The increase in net assets from £5 to £81 suggests some capital strengthening or accumulation of small profits, which is a positive symptom.
• The lack of employees points to a service model likely dependent on directors or subcontractors, minimizing fixed costs but also limiting scale.
• The micro-entity status means simplified reporting but also limited financial complexity.

---

3. Diagnosis

The financial "symptoms" suggest THE LOREM THERAPY LTD is in an early, stable phase with a "healthy but delicate pulse." The company is maintaining positive working capital and has increased its net asset base, which are good signs of internal financial control and operational management.

However, the absolute scale of financial resources is very small, indicating low financial "reserves" or buffer against unexpected shocks. The company’s balance sheet shows minimal capital and limited cash resources, which could constrain growth or ability to absorb disruptions.

No signs of distress such as negative net assets, overdue filings, or director disqualifications are present. The directors appear to maintain good governance and compliance.

Overall, the diagnosis is a young, micro-scale business with stable financial footing but limited capacity for rapid expansion or financial stress.

---

4. Recommendations

To improve financial wellness and strengthen the company’s financial health, consider the following:

• Build Cash Reserves: Aim to increase current assets (cash or equivalents) to at least cover 3-6 months of operating expenses, providing a stronger liquidity buffer against "financial colds" or shocks.
• Increase Capital Base: Explore options to inject additional equity or retained earnings to grow net assets, improving the company’s resilience and creditworthiness.
• Monitor Cash Flow Closely: Maintain a disciplined cash flow management system to avoid sudden liquidity shortages. Consider simple forecasting tools to anticipate potential shortfalls.
• Evaluate Growth Opportunities Carefully: Given the micro-scale and zero employees, growth should be managed cautiously to avoid overstretching resources. Incremental expansion through controlled investments or partnerships may be advisable.
• Maintain Compliance and Transparency: Continue timely filings and governance to avoid penalties or reputational risks that could weaken financial health.

---